POSEIDA THERAPEUTICS INC (PSTX)

US73730P1084 - Common Stock

3.46  +0.54 (+18.49%)

After market: 3.4503 -0.01 (-0.28%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
64.70M130.50M31.20M0.000.00
Operating Expenses
194.21M190.40M172.60M126.50M85.50M
Research and Development
156.77M152.90M136.70M103.50M60.40M
Selling, General, and Administrative Expenses
37.44M37.50M35.90M23.00M18.50M
Operating Income
-129.50M-59.90M-141.40M-126.50M-85.50M
Interest Income/Expense
-8.67M-6.40M-3.40M-3.90M-4.10M
Other Income/Expense
14.85M2.90M300.00K700.00K3.10M
Non Recurring Items
N/AN/A19.50MN/A0.00
Income Before Taxes
-123.32M-63.50M-125.00M-129.80M-86.50M
Income Tax
107.00K500.00K0.000.000.00
Net Income
-123.43M-64.00M-125.00M-129.80M-86.50M
EBITDA
-123.89M-54.73M-136.85M-123.91M-84.31M
 
Per Share Data
EPS Diluted Total Ops
-1.37-0.89-2.01-2.10-1.40
Non GAAP EPS
-1.39-1.09-2.02N/AN/A
 
Statistics
Profit Margin
-190.76%-49.04%-400.64%N/AN/A
Operating Profit Margin
-200.15%-45.90%-453.21%N/AN/A

All data in USD

Charts